Table 2.
Patient Characteristics | Insomnia Item Scorea | |||
---|---|---|---|---|
Socio-Demographic Factors | Total N=654 (100%) |
High Score (≥4) n=135 (100%) |
Low Score (≤3) n=519 (100%) |
p-valueb |
Gender, male | 351 (53.7%) | 60 (44.4%) | 291 (56.1%) | .02 |
Age, mean (range) | 53.9 (18–89) | 53.1 (24–84) | 54.0 (18–89) | .50 |
Ethnicity, Hispanic/Latino | 12 (1.8%) | 3 (2.2%) | 9 (1.7%) | .72 |
Race, minority or multiplec | 48 (7.3%) | 15 (11.1%) | 33 (6.4%) | .06 |
Married/partnered | 454 (69.4%) | 89 (65.9%) | 365 (70.3%) | .40 |
Low income (<35k HH annual) | 153 (23.4%) | 40 (29.6%) | 113 (21.8%) | .06 |
Some college/college graduate | 469 (71.7%) | 92 (68.1%) | 377 (72.6%) | .39 |
Frequent computer use | 520 (79.5%) | 100 (74.1%) | 420 (80.9%) | .09 |
Study Group | .77 | |||
Control | 330 (50.5%) | 70 (51.9%) | 260 (50.1%) | |
Intervention | 324 (49.5%) | 65 (48.1%) | 259 (49.9%) | |
Clinical Factors | ||||
Service line | .10 | |||
Medical | 304 (46.5%) | 55 (40.7%) | 249 (48%) | |
Radiation | 152 (23.2%) | 32 (23.7%) | 120 (23.1%) | |
Transplant | 198 (30.3%) | 48 (35.6%) | 120 (28.9%) | |
Cancer Diagnosis | .26 | |||
Breast | 43 (6.6%) | 11 (8.1%) | 32 (6.2%) | |
Gastrointestinal | 78 (11.9%) | 10 (7.4%) | 68 (13.1%) | |
Genitourinary | 75 (11.5%) | 8 (5.9%) | 67 (12.9%) | |
Gynecological | 62 (9.5%) | 19 (14.1%) | 43 (8.3%0 | |
Head and Neck | 54 (8.3%) | 11 (8.1%) | 43 (8.3%) | |
Leukemia | 102 (15.6%) | 25 (18.5%) | 77 (14.8%) | |
Lung | 40 (6.1%) | 10 (7.45%) | 30 (5.8%) | |
Lymphoma | 103 (15.7%) | 18 (13.3%) | 85 (16.4%) | |
Myeloma | 45 (6.9%) | 9 (6.7%) | 36 (6.9%) | |
Other | 52 (8.0%) | 14 (10.4%) | 38 (7.3%) |
Insomnia item on the Symptom Distress Scale range from 1–5
P-value from Fisher’s exact test (t-test for age) for the association between insomnia groups (low vs high) and the given variables at baseline (socio-demographics and clinical factors).
Includes anyone who reported race as anything other than “White/Caucasian” and those who reported more than one race.